Purchase Order 75F40118P20268
- Not listed
- This is a $5,480 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned manufacturer based in Atlanta, Georgia. The contract is for the delivery of well plates and microelectrodes, which are specialized laboratory equipment used for real-time monitoring of neural and cardiac cellular activities. The contract was set aside for small businesses. Axion Biosystems has a strong track record of providing advanced live cell...
- This is a $23,690.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of advanced laboratory equipment based in Atlanta, Georgia. The contract is for the procurement of laboratory supplies and consumables to support the FDA's Center for Drug Evaluation and Research (CDER). This award is a small business set-aside and is not associated with a larger contract vehicle. Axion Biosystems has a history...
- This is a $140,204.00 firm-fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services' Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the delivery of a Micro-Electrode Assay System, a specialized laboratory instrument used in biomedical research initiatives across agencies like the National Institutes of Health (NIH), EPA, and VA. As a small business set-aside, this award...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment. The $218,346.00 contract is for the Maestro Multiwell System and related service agreement. Axion Biosystems provides the FDA with its proprietary Maestro multi-electrode array (MEA) systems, Maestro Apex automated incubators, and consumables to support the agency's biomedical research and drug...
- <p>The Food and Drug Administration issued a delivery order to Axion Biosystems, Inc. on August 18, 2026, with a ceiling value of $51,900 for Axion multi-well plates for use in the multielectrode array (MEA) Maestro system. The order is firm fixed price and completes on September 30, 2026. Place of performance is Atlanta, Georgia.</p>
- This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the Department of Health and Human Services (HHS). The contract, valued at $12,960.00, is for the delivery of CYTOVIEW MEA 48-WELL WHITE PLATE (BOX OF 5) by the prime contractor, Axion Biosystems, Inc., a foreign-owned for-profit manufacturer of laboratory equipment and instruments. The contract does not have a set-aside designation and has an ultimate...
- The Food and Drug Administration awarded a $242,600 firm fixed-price purchase order to Axion Biosystems, Inc. for an Axion Biosystem Maestro/Microelectrode Array System. The contract was awarded on June 8, 2022, with an ultimate completion date of June 7, 2026, and no small business set-aside was utilized. Performance of the contract is located in Atlanta, Georgia, where Axion Biosystems maintains its headquarters. Axion Biosystems specializes in advanced live cell analysis technologies,...
- This is a firm fixed-price purchase order contract awarded by the U.S. Environmental Protection Agency's Office of Research and Development to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The contract, valued at $90,975.00, is for the delivery of CLASSIC MEA 48 PLATES, which are multi-electrode array plates used in Axion's Maestro live cell analysis platforms. These instruments allow researchers to continuously monitor...
- This federal contract award is for the procurement of microelectrode array (MEA) lab equipment, including the Maestro multi-well MEA system, from Axion Biosystems, Inc. The $163,750.00 firm fixed-price purchase order was issued by the Department of Health and Human Services' Food and Drug Administration. The contract has a completion date of December 1, 2022 and includes two 1-year post-warranty maintenance option periods. Axion Biosystems is a life science company that develops technologies for...
- This federal contract award, with ID HHSF223201510126A, was made by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The $219,708.00 firm-fixed-price purchase order is for the acquisition of a high-throughput microelectrode assay system, plus 4 years of preventive maintenance services. The award does not have a set-aside designation. Axion Biosystems is a provider of live cell...
This is a $19,050.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer based in Atlanta, Georgia. The contract is for the delivery of E-STIM + MEA 48-WELL PLATES, which are specialized scientific instruments and laboratory equipment used in biomedical and drug development research. The contract was set aside for small businesses and has an ultimate completion date of September 13, 2018. Axion Biosystems is a key provider of multi-electrode array (MEA) systems and related technologies to federal research agencies, including the NIH, EPA, and VA. This contract award aligns with the company's expertise in delivering advanced live cell analysis technologies and equipment to support various federal research initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 8/14/18 |